Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Phage therapy could be a safe and effective new treatment for acne.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The botanical treatment for hair loss shows promise, especially for children.

GI197111X is best dissolved in Capmul MCM for trials.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Promising cancer treatments were found, but the manufacturer closed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Topical finasteride is a safe and effective treatment for pattern hair loss with fewer side effects than oral finasteride.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.